Simon S. Jones

6.1k total citations · 3 hit papers
71 papers, 4.7k citations indexed

About

Simon S. Jones is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Simon S. Jones has authored 71 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 24 papers in Hematology and 19 papers in Oncology. Recurrent topics in Simon S. Jones's work include Histone Deacetylase Inhibitors Research (32 papers), Protein Degradation and Inhibitors (21 papers) and Multiple Myeloma Research and Treatments (18 papers). Simon S. Jones is often cited by papers focused on Histone Deacetylase Inhibitors Research (32 papers), Protein Degradation and Inhibitors (21 papers) and Multiple Myeloma Research and Treatments (18 papers). Simon S. Jones collaborates with scholars based in United States, United Kingdom and China. Simon S. Jones's co-authors include Randal J. Kaufman, Rodney M. Hewick, Charles B. Shoemaker, Jasbir Seehra, Colin B. Reese, Min Yang, Noopur Raje, Eugene L. Brown, Elizabeth C. Orr and Patricia A. Temple and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Simon S. Jones

63 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins

1985 1.1k citations Simon S. Jones et al. profile →
Isolation and characterization of genomic and cDNA clones of human erythropoietin

1985 829 citations Jasbir Seehra, Simon S. Jones et al. profile →
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

2012 488 citations David Tamang, Min Yang et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon S. Jones United States	24	2.9k	1.3k	1.0k	654	438	71	4.7k
Paolo Salomoni United Kingdom	45	4.8k 1.7×	1.1k 0.9×	1.4k 1.4×	852 1.3×	527 1.2×	104	6.5k
Yaacov Ben‐David Canada	37	3.4k 1.2×	577 0.4×	1.2k 1.2×	753 1.2×	479 1.1×	130	5.3k
Gregory Hollis United States	36	2.7k 0.9×	454 0.3×	1.0k 1.0×	996 1.5×	548 1.3×	101	5.1k
Rab K. Prinjha United Kingdom	40	4.9k 1.7×	1.3k 1.0×	697 0.7×	1.3k 2.0×	334 0.8×	106	6.7k
Rikiro Fukunaga Japan	32	3.3k 1.2×	568 0.4×	1.3k 1.3×	1.7k 2.5×	831 1.9×	71	5.7k
Hsieng S. Lu United States	30	2.4k 0.8×	1.1k 0.8×	1.6k 1.6×	1.3k 2.0×	715 1.6×	54	5.1k
Michaela Scherr Germany	36	3.3k 1.1×	585 0.4×	654 0.6×	793 1.2×	704 1.6×	111	5.5k
Oliver H. Krämer Germany	43	4.8k 1.7×	469 0.4×	1.9k 1.9×	643 1.0×	354 0.8×	150	6.3k
Hermann Gram Switzerland	40	3.8k 1.3×	344 0.3×	763 0.7×	1.6k 2.5×	348 0.8×	74	6.1k
Silvano Capitani Italy	51	4.8k 1.7×	975 0.7×	1.3k 1.3×	1.6k 2.4×	464 1.1×	262	7.9k

Countries citing papers authored by Simon S. Jones

Since Specialization

Citations

This map shows the geographic impact of Simon S. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon S. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon S. Jones more than expected).

Fields of papers citing papers by Simon S. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon S. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon S. Jones. The network helps show where Simon S. Jones may publish in the future.

Co-authorship network of co-authors of Simon S. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Simon S. Jones. A scholar is included among the top collaborators of Simon S. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon S. Jones. Simon S. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berdeja, Jesús G., Min Yang, Noopur Raje, et al.. (2024). Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. Carolina Digital Repository (University of North Carolina at Chapel Hill).

Johnson, Danielle P., Samuel Bennett, Simon S. Jones, et al.. (2017). HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia. Leukemia. 32(1). 49–60. 34 indexed citations

Vogl, Dan T., Noopur Raje, Sundar Jagannath, et al.. (2017). Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma. Clinical Cancer Research. 23(13). 3307–3315. 192 indexed citations

Min, Chengyin, Nathan W. Moore, Jeffrey R. Shearstone, et al.. (2017). Selective Inhibitors of Histone Deacetylases 1 and 2 Synergize with Azacitidine in Acute Myeloid Leukemia. PLoS ONE. 12(1). e0169128–e0169128. 19 indexed citations

North, Brian J., et al.. (2017). Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor. PLoS ONE. 12(3). e0173507–e0173507. 40 indexed citations

Yee, Andrew J., William Bensinger, Jeffrey G. Supko, et al.. (2016). Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial. The Lancet Oncology. 17(11). 1569–1578. 162 indexed citations

Shearstone, Jeffrey R., Olga Golonzhka, Apurva Chonkar, et al.. (2016). Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2. PLoS ONE. 11(4). e0153767–e0153767. 28 indexed citations

Powers, John J., Eva Sahakian, Limin Xing, et al.. (2014). Histone Deacetylase 6 (HDAC6) As a Regulator of Immune Check-Point Molecules in Chronic Lymphocytic Leukemia (CLL). Blood. 124(21). 3311–3311. 10 indexed citations

Shearstone, Jeffrey R., John H. van Duzer, Simon S. Jones, & Matthew Jarpe. (2013). Mechanistic Insights Into Fetal Hemoglobin (HbF) Induction Through Chemical Inhibition Of Histone Deacetylase 1 and 2 (HDAC1/2). Blood. 122(21). 2253–2253. 2 indexed citations

10.

Boroujerdi, Arezue, Simon S. Jones, & Daniel W. Bearden. (2011). NMR analysis of metabolic responses to extreme conditions of the temperature-dependent coral pathogen Vibrio coralliilyticus. Letters in Applied Microbiology. 54(3). 209–216. 11 indexed citations

11.

Saraswat, Lakshmi D., et al.. (2005). Affinity Ligand Selection from a Library of Small Molecules: Assay Development, Screening, and Application. Biotechnology Progress. 21(1). 300–308. 6 indexed citations

12.

Saraswat, Lakshmi D., et al.. (2003). A High-Throughput Method for Enzyme Kinetic Studies. SLAS DISCOVERY. 8(5). 544–554. 9 indexed citations

13.

Gould, Stephen E., et al.. (2002). BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells1. Kidney International. 61(1). 51–60. 198 indexed citations

14.

Tang, Jin, et al.. (1997). A Novel Cytosolic Calcium-independent Phospholipase A2 Contains Eight Ankyrin Motifs. Journal of Biological Chemistry. 272(13). 8567–8575. 264 indexed citations

15.

Balboa, Marı́a A., Jesús Balsinde, Simon S. Jones, & Edward A. Dennis. (1997). Identity between the Ca2+-independent Phospholipase A2 Enzymes from P388D1 Macrophages and Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 272(13). 8576–8580. 140 indexed citations

16.

Paul, Stephan, David Merberg, Heather Finnerty, et al.. (1992). Molecular cloning of the cDNA encoding a receptor tyrosine kinase‐related molecule with a catalytic region homologous to c‐ met. The International Journal Of Cell Cloning. 10(5). 309–314. 16 indexed citations

17.

Jones, Simon S., et al.. (1985). Activation of Ha- ras p21 by Substitution, Deletion, and Insertion Mutations. Molecular and Cellular Biology. 5(8). 1809–1813. 7 indexed citations

18.

Jones, Simon S., et al.. (1981). The protection of uracil and guanine residues in oligonucleotide synthesis. Tetrahedron Letters. 22(47). 4755–4758. 58 indexed citations

19.

Mendelson, Wilford L., et al.. (1980). Intramolecular friedel-crafts alkylations. II. An efficient synthesis of biologically active 1,2,3,4-tetrahydroisoquinolines. Tetrahedron Letters. 21(15). 1393–1396. 21 indexed citations

20.

Jones, Simon S.. (1970). V.l.f. Techniques for Navigation. Journal of Navigation. 23(1). 23–26. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact